Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1634-1637

  Tavio, M ^a   Nasti, G ^a   Simonelli, C ^a   Vaccher, E ^a   De Paoli, P ^a   Giacca, M ^b   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

HIV infection; Human chorionic gonadotropin; Kaposi's sarcoma

Indexed keywords

CHORIONIC GONADOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER CHEMOTHERAPY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR GROWTH; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; SARCOMA, KAPOSI; VIRAL LOAD;

EID: 0032169482     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00154-3     Document Type: Article

References (19)

1. 1. Reynolds P, Layefsky ME, Saunders LD, Lemp CF, Payne SF. Kaposi's sarcoma reporting in San Francisco: a comparison of AIDS and cancer surveillance system. J Acq Immun Def Synd 1990, 3, 8-13.
2. 2. Reynolds P, Saunders LD, Layefsky ME, Lemp CF. An update on Kaposi's sarcoma reporting in San Francisco. J Acq Immun Def Synd 1991, 4, 825-826.
3. 3. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case - control and longitudinal study in the multicenter AIDS cohort study (MACS) population. Am J Epidemiol 1993, 138, 256-265.
4. 4. Gill PS, Axil B, Colletti P. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med 1989, 87, 57-61.
5. 5. Bourinbaiar AS, Nagorny R. Inhibitory effect of human chorionic gonadotropin (hCG) on HIV-1 transmission from lymphocytes to trophoblasts. FEBS 1992, 309, 82-84.
6. 6. Bourinbaiar AS, Lee-Huang S. Anti-HIV effect of beta subunit of human chorionic gonadotropin (beta HCG) in vitro. Immunol 1995, 44, 13-81.
7. 7. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995, 375, 64-69.
8. 8. Harris PJ. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. Lancet 1995, 346, 118-119.
9. 9. Bower M, Fife K, Nelson M, Youle M. Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma. Lancet 1995, 346, 642.
10. 10. von Oberbeck J, Percy L, Iten A, Pechère M, Ruffieux P, Hirschel B. Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma. Lancet 1995, 346, 642-643.
11. 11. Gill PS, Lunardi-Iskandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med 1996, 335, 1261-1269.
12. 12. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996, 348(9023), 283-291.
13. 13. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med 1996, 335(15), 1081-1090.
14. 14. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response and staging criteria. J Clin Oncol 1989, 7, 1201-1207.
15. 15. Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987, 14(Suppl. 2)), 13-18.
16. 16. Comar M, Marzio G, D'Agaro P, Giacca M. Quantitative dynamics of HIV-1 expression. AIDS Res Hum Retrov 1996, 12, 117-126.
17. 17. Yamaguchi NH, Varella D, Guerra CVC, et al. A case report with unexpected adverse events in one AIDS related Kaposi's sarcoma treated with beta human chorionic gonadotrophin (beta-HCG). Proc ASCO 1996, 15, 309 (abs. #867).
18. 18. Krown SE. Kaposi's sarcoma. What's human chorionic gonadotropin got to do with it? N Engl J Med 1996, 335, 1309-1310.
19. 19. Albini A, Paglieri I, Orengo G, et al. The β-core fragment of human chorionic gonadotropin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 1997, 11, 713-721.